scispace - formally typeset
G

Gabriela D. Colpo

Researcher at University of Texas Health Science Center at Houston

Publications -  64
Citations -  2286

Gabriela D. Colpo is an academic researcher from University of Texas Health Science Center at Houston. The author has contributed to research in topics: Bipolar disorder & Medicine. The author has an hindex of 22, co-authored 58 publications receiving 1752 citations. Previous affiliations of Gabriela D. Colpo include Universidade Federal do Rio Grande do Sul & University of Texas at Austin.

Papers
More filters
Journal ArticleDOI

Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: A systematic review and meta-regression analysis

TL;DR: BDNF levels are consistently reduced during manic and depressive episodes and recover after treatment for acute mania, and data suggest that peripheral BDNF could be used as a biomarker of mood states and disease progression for BD.
Journal ArticleDOI

Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies.

TL;DR: The data suggest that SH-SY5Y cells differentiated by 7 days with the protocol described here represent a more suitable experimental model for studying the molecular and cellular mechanisms underlying the pathophysiology of PD.
Journal ArticleDOI

A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients.

TL;DR: The pro-inflammatory cytokines were elevated and the anti-inflammatoryocytes were reduced in BD patients, particularly during manic and depressive phases when compared to the controls, indicating that inflammation may be associated with acute phases of BD.
Journal ArticleDOI

Attention-Deficit/Hyperactivity Disorder And Inflammation: What Does Current Knowledge Tell Us? A Systematic Review.

TL;DR: Evidence points to the association of ADHD with inflammatory processes, but more studies are warranted, despite the significant heterogeneity and contradictory results.
Journal ArticleDOI

Therapeutic use of omega-3 fatty acids in bipolar disorder.

TL;DR: It is proposed that the n-3–BDNF association is involved in the pathophysiology of BD and represents a promising target for developing a novel class of rationally devised therapies.